Detalles de la búsqueda
1.
[Research Progress of Fibroblast Growth Factor Receptor Signaling Pathway in Breast Cancer].
Zhongguo Yi Xue Ke Xue Yuan Xue Bao
; 44(1): 136-141, 2022 Feb.
Artículo
en Zh
| MEDLINE | ID: mdl-35300776
2.
Decoding the dynamic DNA methylation and hydroxymethylation landscapes in endodermal lineage intermediates during pancreatic differentiation of hESC.
Nucleic Acids Res
; 46(6): 2883-2900, 2018 04 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29394393
3.
Plasma cell-free DNA chromosomal instability analysis by low-pass whole-genome sequencing to monitor breast cancer relapse.
Breast Cancer Res Treat
; 178(1): 63-73, 2019 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-31364001
4.
Comprehensive mutation detection of BRCA1/2 genes reveals large genomic rearrangements contribute to hereditary breast and ovarian cancer in Chinese women.
BMC Cancer
; 19(1): 551, 2019 Jun 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31174498
5.
Novel germline mutations and unclassified variants of BRCA1 and BRCA2 genes in Chinese women with familial breast/ovarian cancer.
BMC Cancer
; 16: 64, 2016 Feb 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-26852015
6.
Serum protein S100A9, SOD3, and MMP9 as new diagnostic biomarkers for pulmonary tuberculosis by iTRAQ-coupled two-dimensional LC-MS/MS.
Proteomics
; 15(1): 58-67, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25332062
7.
ER-positive and BRCA2-mutated breast cancer: a literature review.
Eur J Med Res
; 29(1): 30, 2024 Jan 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38184581
8.
HR-positive/HER2-negative breast cancer arising in patients with or without BRCA2 mutation: different biological phenotype and similar prognosis.
Ther Adv Med Oncol
; 16: 17588359241242613, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38606163
9.
Characterizing the Efficacy and Safety of Chemotherapy Plus Everolimus in HER2-Negative Metastatic Breast Cancer Harboring Altered PI3K/AKT/mTOR.
Discov Med
; 36(182): 527-537, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38531793
10.
The progress in our understanding of CIN in breast cancer research.
Front Oncol
; 13: 1067735, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36874134
11.
The role of TSC2 in breast cancer: a literature review.
Front Oncol
; 13: 1188371, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37251941
12.
Resistance to anti-HER2 therapy associated with the TSC2 nonsynonymous variant c.4349 C > G (p.Pro1450Arg) is reversed by CDK4/6 inhibitor in HER2-positive breast cancer.
NPJ Breast Cancer
; 9(1): 36, 2023 May 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37160904
13.
FOXK2 amplification and overexpression promotes breast cancer development and chemoresistance.
bioRxiv
; 2023 May 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-37398114
14.
A comprehensive analysis of Fanconi anemia genes in Chinese patients with high-risk hereditary breast cancer.
J Cancer Res Clin Oncol
; 149(15): 14303-14313, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37566130
15.
Pyrotinib plus docetaxel as first-line treatment for HER2-positive metastatic breast cancer: the PANDORA phase II trial.
Nat Commun
; 14(1): 8314, 2023 Dec 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38097605
16.
High chromosome instability identified by low-pass whole-genome sequencing assay is associated with TP53 copy loss and worse prognosis in BRCA1 germline mutation breast cancer.
Breast Cancer
; 29(1): 103-113, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34403063
17.
Cardiac Safety in Breast Cancer Patients Receiving Pegylated Liposome Doxorubicin Sequential Anti-HER2 Monoclonal Antibody Therapy.
Front Pharmacol
; 13: 883600, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35991878
18.
Comprehensive Analysis of Somatic Reversion Mutations in Homologous Recombination Repair (HRR) Genes in A Large Cohort of Chinese Pan-cancer Patients.
J Cancer
; 13(4): 1119-1129, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35281878
19.
WITHDRAWN: miR-543 promotes proliferation and invasion of non-small cell lung cancer cells by inhibiting PTEN.
Biochem Biophys Res Commun
; 2016 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27040768
20.
BRCA1 Reversion Mutation Confers Resistance to Olaparib and Camrelizumab in a Patient with Breast Cancer Liver Metastasis.
J Breast Cancer
; 24(5): 474-480, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34652076